Company Overview

Update
Founded:
1997
Headquarters:
South San Francisco, CA
Funding:
$53.70M
Categories:
Biotechnology

diaDexus is a biotechnology company focused on the development and commercialization of diagnostic products with high clinical value.

Description

Update

diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value.

The company's lead product, the PLAC Test, measures Lp-PLA2 (lipoprotein-associated phospholipase A2) a vascular-specific inflammatory enzyme implicated in the formation of rupture-prone plaque. It is plaque rupture and thrombosis, not stenosis, that cause the majority of cardiovascular events. The PLAC Test is the only blood test cleared by the FDA as an aid in assessing risk for coronary heart disease, and ischemic stroke associated with atherosclerosis.

Current Team (8)

Update

Board Members and Advisors (5)

Update

Products (1)

Update
  • Cb default image

    PLAC Test for Lp-PLA2

    The PLAC Test for Lp-PLA2 The PLAC Test for Lp-PLA2 is the only blood test cleared by the FDA to..

Funding Rounds (3) - $53.70M

Update

Investors (7)

Update

Offices/Locations (1)

Update
  • HQ

    343 Oyster Point Boulevard

    South San Francisco, CA 94080-1913

    USA

Images (1)

Update
  • 93e9aa54231bbb78512bec85a23054c3